We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+4.88%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$39.2M
AUM Growth
-$20.3M
Cap. Flow
-$13.3M
Cap. Flow %
-33.9%
Top 10 Hldgs %
72.38%
Holding
26
New
–
Increased
4
Reduced
6
Closed
7

Top Buys

Rank Stock Value
1
YARW
Yarrow Bioscience
YARW
+$1.6M
2
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$1.52M
3
WBA
Walgreens Boots Alliance
WBA
+$1.06M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$3.35M
2
LH icon
Labcorp
LH
+$3.16M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$2.69M
4
ABBV icon
AbbVie
ABBV
+$2.2M
5
MCK icon
McKesson
MCK
+$2.17M

Sector Composition

Rank Sector Weight
1 Healthcare 78.57%
2 Miscellaneous 18.89%
3 Consumer Staples 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
26
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-30,000
Closed -$2.69M
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Healthcare Value Capital held 26 positions worth $39.2M, down 34% from $59.5M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Healthcare Value Capital withdrew a net $13.3M in Q2 2020, closing 7 positions and reducing 6 holdings. Its most notable exit was AstraZeneca, an estimated $3.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 73% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Healthcare Value Capital added an estimated $1.6M to Yarrow Bioscience.

  • Healthcare Value Capital added most to Yarrow Bioscience in Q2 2020, an estimated $1.6M increase.
  • Healthcare Value Capital's biggest Q2 2020 reduction was AbbVie, cutting an estimated $2.2M.
  • Healthcare Value Capital fully exited AstraZeneca in Q2 2020, selling an estimated $3.35M.
  • Healthcare Value Capital's ten largest holdings make up 72% of its $39.2M portfolio in Q2 2020.
  • Healthcare Value Capital opened 0 new positions and closed 7 in Q2 2020.
  • Healthcare Value Capital's portfolio value fell 34% quarter-over-quarter to $39.2M.

Based on Healthcare Value Capital's 13F filing for Q2 2020, filed 14 Aug 2020.